Amicus Therapeutics (FOLD) Misses Q4 EPS by 6c
Tweet
Share
E-mailGet Alerts FOLD Hot Sheet
Price: $14.49 --0%
Financial Fact:
Research and development: 32.46M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Research and development: 32.46M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18).
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Barclays says AI trade is maturing, favors greater diversification
- Can global equities keep rising? UBS sees these factors driving upside
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
